Search Clear search
SearchSite Search

Analyst consensus

Check the latest analyst estimates by VARA Research

A wide range of sell-side analysts provide coverage of dsm-firmenich for their clients and the broader market.

Sell-side analyst coverage

InstitutionAnalyst
ABN AMROStefano Toffano
Bank of America Merrill LynchMatthew Yates
BarclaysAlex Sloane
Berenberg BankSebastian Bray
BernsteinThomas Swoboda
CitigroupSebastian Satz/Ranulf Orr
Davy ResearchCathal Kenny
Deutsche BankVirginie Boucher-Ferte
EquitaMassimo Bonisoli
Exane BNP ParibasNicola Tang
Goldman SachsGeorgina Fraser
HSBCMartin Evans
INGReg Watson
JefferiesChris Counihan
JP MorganChetan Udeshi
KBC SecuritiesWim Hoste
Kepler ChevreuxMartin Rödiger
Morgan Stanley Lisa De Neve
MorningstarRob Hales
DeGroof PetercamFernand de Boer
Redburn AtlanticArtem Chubarov
StifelIsha Sharma
UBSCharles Eden
Van Lanschot Kempen Eric Wilmer

Disclaimer
Any opinions, forecasts, estimates, projections, or predictions regarding DSM’s performance made by the analysts are theirs alone and do not represent the opinions, forecasts, estimates, projections, or predictions of DSM or its management. By providing the names of the analysts, DSM does not imply its endorsement of or concurrence with their reports, conclusions, or recommendations. DSM assumes no liability for the accuracy of the information provided by analysts and undertakes no obligation to update this information.

                  Consensus figures per 12 April 2024

The most recent consensus figures provided by Vara Research are detailed below. The figures are based on the estimates given by the banks that were approached.

 Q1 2023Q3 2023Q4 2023FY 2023 Q1 2024 EFY 2024 E
dsm-firmenich, total sales      
  - Number of Estimates    1212
  - Highest    3,20513,052
  - Consensus3,1223,0463,11212,3103,11012,662
  - Median    3,12012,627
  - Lowest    2,97512,339
P&B, sales      
  - Number of Estimates    1111
  - Highest    1,0373,967
  - Consensus9729209143,7099833,821
  - Median    9873,832
  - Lowest    9233,710
TTH, sales      
  - Number of Estimates    1111
  - Highest    7933,210
  - Consensus7727377683,0387763,136
  - Median    7803,129
  - Lowest    7453,084
HNC, sales      
  - Number of Estimates    1111
  - Highest    6052,425
  - Consensus5825455812,2705702,331
  - Median    5762,342
  - Lowest    5312,242
ANH, sales      
  - Number of Estimates    1111
  - Highest    8363,395
  - Consensus7858238333,2277643,312
  - Median    7463,321
  - Lowest    7073,198
Corporate, sales      
  - Number of Estimates    1111
  - Highest    2080
  - Consensus112116661666
  - Median    1766
  - Lowest    1150
dsm-firmenich, total organic sales growth in %      
  - Number of Estimates    1212
  - Highest    3.05.7
  - Consensus--7.0-3.0-5.00.83.2
  - Median    1.23.4
  - Lowest    -1.50.5
P&B, organic sales growth in %      
  - Number of Estimates    1111
  - Highest    7.07.0
  - Consensus-0.02.01.02.73.6
  - Median    3.03.6
  - Lowest    -4.00.5
TTH, organic sales growth in %      
  - Number of Estimates    1111
  - Highest    5.56.1
  - Consensus--5.0-1.0-1.02.43.7
  - Median    2.03.4
  - Lowest    0.02.6
HNC, organic sales growth in %      
  - Number of Estimates    1111
  - Highest    5.06.0
  - Consensus--8.04.0-4.0-1.03.1
  - Median    -1.02.7
  - Lowest    -6.10.3
ANH, organic sales growth in %      
  - Number of Estimates    1111
  - Highest    7.05.0
  - Consensus--13.0-12.0-13.0-2.13.1
  - Median    -2.54.3
  - Lowest    -9.0-0.4
dsm-firmenich, total Adj. EBITDA      
  - Number of Estimates    1212
  - Highest    4782,071
  - Consensus5214094391,7774651,990
  - Median    4671,984
  - Lowest    4511,927
P&B, Adj. EBITDA      
  - Number of Estimates    1011
  - Highest    223887
  - Consensus210212192783212832
  - Median    217827
  - Lowest    188791
TTH, Adj. EBITDA      
  - Number of Estimates    1011
  - Highest    159625
  - Consensus152134133556145599
  - Median    144599
  - Lowest    134572
HNC, Adj. EBITDA      
  - Number of Estimates    1011
  - Highest    105443
  - Consensus120759438991408
  - Median    86408
  - Lowest    79375
ANH, Adj. EBITDA      
  - Number of Estimates    1011
  - Highest    48263
  - Consensus68113212837234
  - Median    36240
  - Lowest    33195
Corporate, Adj. EBITDA      
  - Number of Estimates    1011
  - Highest    -16-64
  - Consensus-29-23-12-79-20-77
  - Median    -20-80
  - Lowest    -25-90
Adj. EBIT      
  - Number of Estimates    010
  - Highest    -1,125
  - Consensus---666-876
  - Median    -814
  - Lowest    -703
Core adj. EBIT      
  - Number of Estimates    011
  - Highest    -1,415
  - Consensus---850-1,105
  - Median    -1,043
  - Lowest    -993
Core adj. net profit      
  - Number of Estimates    011
  - Highest    -790
  - Consensus---555-708
  - Median    -714
  - Lowest    -630
Core adj. EPS      
  - Number of Estimates    011
  - Highest    -2.90
  - Consensus---2.03-2.64
  - Median    -2.62
  - Lowest    -2.37

Disclaimer
This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.

 

Explore more

  • Sustainability

    As a company formed of two sustainability leaders, we’re determined to keep growing our positive impact – for the good of people, climate, and nature.

    Read more

  • Science & Research

    With over a century of scientific leadership under our belts, we keep pushing the boundaries of what’s possible to improve billions of lives.

    Read more